Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-600
Closed -$10.8K 12352
2025
Q1
$10.8K Sell
600
-300
-33% -$5K ﹤0.01% 13526
2024
Q4
$14.3K Buy
900
+700
+350% +$11.5K ﹤0.01% 13409
2024
Q3
$3.41K Buy
200
+100
+100% +$1.73K ﹤0.01% 13658
2024
Q2
$1.76K Buy
+100
New +$1.74K ﹤0.01% 13781
2023
Q4
Sell
-2,500
Closed -$39.5K 14188
2023
Q3
$39.5K Sell
2,500
-2,500
-50% -$38.5K ﹤0.01% 12006
2023
Q2
$70.2K Buy
5,000
+1,000
+25% +$12.2K ﹤0.01% 11386
2023
Q1
$44.6K Buy
+4,000
New +$52.5K ﹤0.01% 12308
2020
Q1
Sell
-9,000
Closed -$244K 9528
2019
Q4
$244K Buy
+9,000
New +$243K ﹤0.01% 7886

Other funds holding AFYA

Citadel Advisors's AFYA Position: Q1 2026 in Review

Citadel Advisors opened a new position in Afya (AFYA) in Q1 2026: 48,887 shares worth $727K. The stake represents ﹤0.01% of the portfolio and ranks #8421 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in AFYA as recently as Q3 2025.

Citadel Advisors first reported a position in AFYA in Q4 2019 and has held it in 22 quarters since. The position peaked at $3.8M in Q4 2022. 54 funds tracked by Wall St. Rank hold AFYA as of Q1 2026.

  • Citadel Advisors held 48,887 shares of Afya worth $727K as of Q1 2026.
  • Afya was a new Citadel Advisors position in Q1 2026.
  • Afya made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8421 holding.
  • Citadel Advisors first reported a position in Afya in Q4 2019 and has held it in 22 quarters since.
  • Citadel Advisors's Afya position peaked at $3.8M in Q4 2022.
  • 54 funds tracked by Wall St. Rank held Afya as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.